Administrative Practices and Procedures; Formal Evidentiary Public Hearing

ICR 201805-0910-009

OMB: 0910-0191

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2018-06-22
ICR Details
0910-0191 201805-0910-009
Historical Active 201504-0910-007
HHS/FDA OC
Administrative Practices and Procedures; Formal Evidentiary Public Hearing
Extension without change of a currently approved collection   No
Regular
Approved without change 08/07/2018
Retrieve Notice of Action (NOA) 07/05/2018
  Inventory as of this Action Requested Previously Approved
08/31/2021 36 Months From Approved 09/30/2018
227 0 227
5,194 0 5,194
0 0 0

Section 12.45 (21 CFR 12.45) issued under section 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 371), sets forth the format and procedures for any interested person to file a petition to participate in a formal evidentiary hearing, either personally or through a representative. Section 12.45 requires that any person filing a notice of participation state their specific interest in the proceedings, including the specific issues of fact about which the person desires to be heard. This section also requires that the notice include a statement that the person will present testimony at the hearing and will comply with specific requirements in 21 CFR 12.85, or, in the case of a hearing before a Public Board of Inquiry, concerning disclosure of data and information by participants (21 CFR 13.25). In accordance with sec. 12.45(e) the presiding officer may omit a participant's appearance.

US Code: 21 USC 371 Name of Law: FFDCA
  
None

Not associated with rulemaking

  83 FR 7742 02/22/2018
83 FR 30736 06/29/2018
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 227 227 0 0 0 0
Annual Time Burden (Hours) 5,194 5,194 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$273,516
No
    Yes
    No
No
No
No
Uncollected
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/05/2018


© 2024 OMB.report | Privacy Policy